nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Hydrocortisone—allergic rhinitis	0.378	1	CrCtD
Danazol—PGR—Betamethasone—allergic rhinitis	0.0482	0.224	CbGbCtD
Danazol—SHBG—Hydrocortisone—allergic rhinitis	0.0433	0.201	CbGbCtD
Danazol—PGR—Dexamethasone—allergic rhinitis	0.0281	0.13	CbGbCtD
Danazol—CYP19A1—Betamethasone—allergic rhinitis	0.0271	0.126	CbGbCtD
Danazol—Prednisone—Flunisolide—allergic rhinitis	0.0162	0.0529	CrCrCtD
Danazol—CYP19A1—Dexamethasone—allergic rhinitis	0.0158	0.0734	CbGbCtD
Danazol—Formestane—Hydrocortisone—allergic rhinitis	0.015	0.049	CrCrCtD
Danazol—Hydrocortisone—Flunisolide—allergic rhinitis	0.0132	0.0431	CrCrCtD
Danazol—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.0124	0.0406	CrCrCtD
Danazol—CYP3A4—Flunisolide—allergic rhinitis	0.0101	0.0468	CbGbCtD
Danazol—Norethindrone—Hydrocortisone—allergic rhinitis	0.00996	0.0326	CrCrCtD
Danazol—Cortisone acetate—Hydrocortisone—allergic rhinitis	0.00965	0.0316	CrCrCtD
Danazol—CYP3A4—Olopatadine—allergic rhinitis	0.00946	0.044	CbGbCtD
Danazol—Cortisone acetate—Methylprednisolone—allergic rhinitis	0.00911	0.0298	CrCrCtD
Danazol—Testolactone—Methylprednisolone—allergic rhinitis	0.00884	0.0289	CrCrCtD
Danazol—Testolactone—Dexamethasone—allergic rhinitis	0.0087	0.0284	CrCrCtD
Danazol—Testolactone—Betamethasone—allergic rhinitis	0.0087	0.0284	CrCrCtD
Danazol—Fluoxymesterone—Hydrocortisone—allergic rhinitis	0.00861	0.0282	CrCrCtD
Danazol—Testolactone—Triamcinolone—allergic rhinitis	0.0085	0.0278	CrCrCtD
Danazol—Prednisone—Hydrocortisone—allergic rhinitis	0.00838	0.0274	CrCrCtD
Danazol—Testosterone Propionate—Hydrocortisone—allergic rhinitis	0.00838	0.0274	CrCrCtD
Danazol—Progesterone—Hydrocortisone—allergic rhinitis	0.00838	0.0274	CrCrCtD
Danazol—Methyltestosterone—Hydrocortisone—allergic rhinitis	0.00817	0.0267	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—allergic rhinitis	0.00811	0.0265	CrCrCtD
Danazol—Fluoxymesterone—Betamethasone—allergic rhinitis	0.00799	0.0261	CrCrCtD
Danazol—Fluoxymesterone—Dexamethasone—allergic rhinitis	0.00799	0.0261	CrCrCtD
Danazol—Prednisone—Methylprednisolone—allergic rhinitis	0.00791	0.0259	CrCrCtD
Danazol—Testolactone—Prednisolone—allergic rhinitis	0.00787	0.0257	CrCrCtD
Danazol—Fluoxymesterone—Triamcinolone—allergic rhinitis	0.00781	0.0255	CrCrCtD
Danazol—Prednisone—Dexamethasone—allergic rhinitis	0.00779	0.0255	CrCrCtD
Danazol—Prednisone—Betamethasone—allergic rhinitis	0.00779	0.0255	CrCrCtD
Danazol—Prednisone—Triamcinolone—allergic rhinitis	0.00761	0.0249	CrCrCtD
Danazol—Testosterone—Hydrocortisone—allergic rhinitis	0.00728	0.0238	CrCrCtD
Danazol—Fluoxymesterone—Prednisolone—allergic rhinitis	0.00723	0.0237	CrCrCtD
Danazol—Prednisone—Prednisolone—allergic rhinitis	0.00705	0.0231	CrCrCtD
Danazol—Progesterone—Prednisolone—allergic rhinitis	0.00705	0.0231	CrCrCtD
Danazol—Methyltestosterone—Prednisolone—allergic rhinitis	0.00687	0.0225	CrCrCtD
Danazol—Hydrocortisone—Methylprednisolone—allergic rhinitis	0.00645	0.0211	CrCrCtD
Danazol—Hydrocortisone—Betamethasone—allergic rhinitis	0.00635	0.0208	CrCrCtD
Danazol—Hydrocortisone—Dexamethasone—allergic rhinitis	0.00635	0.0208	CrCrCtD
Danazol—Hydrocortisone—Triamcinolone—allergic rhinitis	0.0062	0.0203	CrCrCtD
Danazol—Testosterone—Prednisolone—allergic rhinitis	0.00612	0.02	CrCrCtD
Danazol—CYP3A4—Loratadine—allergic rhinitis	0.00578	0.0269	CbGbCtD
Danazol—CYP3A4—Montelukast—allergic rhinitis	0.00578	0.0269	CbGbCtD
Danazol—Hydrocortisone—Prednisolone—allergic rhinitis	0.00575	0.0188	CrCrCtD
Danazol—CYP3A4—Methylprednisolone—allergic rhinitis	0.00529	0.0246	CbGbCtD
Danazol—CYP3A4—Triamcinolone—allergic rhinitis	0.00401	0.0186	CbGbCtD
Danazol—CYP3A4—Betamethasone—allergic rhinitis	0.00344	0.016	CbGbCtD
Danazol—CYP3A4—Prednisolone—allergic rhinitis	0.00339	0.0158	CbGbCtD
Danazol—CYP3A4—Hydrocortisone—allergic rhinitis	0.00321	0.015	CbGbCtD
Danazol—CCL2—IL1 and megakaryotyces in obesity—TLR1—allergic rhinitis	0.00209	0.108	CbGpPWpGaD
Danazol—CYP3A4—Dexamethasone—allergic rhinitis	0.002	0.0093	CbGbCtD
Danazol—CCL2—exocrine gland—allergic rhinitis	0.00171	0.174	CbGeAlD
Danazol—CCL2—respiratory system—allergic rhinitis	0.000888	0.0907	CbGeAlD
Danazol—CCL2—IL23-mediated signaling events—IL17A—allergic rhinitis	0.000848	0.044	CbGpPWpGaD
Danazol—CCL2—Chemokine receptors bind chemokines—CCL11—allergic rhinitis	0.000838	0.0434	CbGpPWpGaD
Danazol—CCL2—eye—allergic rhinitis	0.000811	0.0829	CbGeAlD
Danazol—CCL2—epithelium—allergic rhinitis	0.000742	0.0758	CbGeAlD
Danazol—CCL2—bronchus—allergic rhinitis	0.000731	0.0747	CbGeAlD
Danazol—CCL2—skin of body—allergic rhinitis	0.000706	0.0721	CbGeAlD
Danazol—CCL2—trachea—allergic rhinitis	0.000656	0.067	CbGeAlD
Danazol—CCL2—IL1 and megakaryotyces in obesity—ICAM1—allergic rhinitis	0.00063	0.0327	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL5—allergic rhinitis	0.000474	0.0245	CbGpPWpGaD
Danazol—CCL2—lung—allergic rhinitis	0.000471	0.0482	CbGeAlD
Danazol—PGR—respiratory system—allergic rhinitis	0.000467	0.0477	CbGeAlD
Danazol—CCL2—IL1 and megakaryotyces in obesity—NFKB1—allergic rhinitis	0.000399	0.0207	CbGpPWpGaD
Danazol—PGR—epithelium—allergic rhinitis	0.00039	0.0398	CbGeAlD
Danazol—ESR1—respiratory system—allergic rhinitis	0.000365	0.0373	CbGeAlD
Danazol—PGR—Ovarian Infertility Genes—SMAD3—allergic rhinitis	0.00036	0.0186	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL4—allergic rhinitis	0.000353	0.0183	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL10—allergic rhinitis	0.000346	0.0179	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000345	0.0179	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL4—allergic rhinitis	0.000337	0.0175	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—CD4—allergic rhinitis	0.000328	0.017	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000315	0.0163	CbGpPWpGaD
Danazol—AR—epithelium—allergic rhinitis	0.000311	0.0317	CbGeAlD
Danazol—AR—bronchus—allergic rhinitis	0.000306	0.0313	CbGeAlD
Danazol—ESR1—epithelium—allergic rhinitis	0.000305	0.0312	CbGeAlD
Danazol—GNRHR—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.000303	0.0157	CbGpPWpGaD
Danazol—AR—skin of body—allergic rhinitis	0.000295	0.0302	CbGeAlD
Danazol—CCL2—IL23-mediated signaling events—NFKB1—allergic rhinitis	0.000282	0.0146	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—ICAM1—allergic rhinitis	0.000281	0.0145	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000279	0.0145	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000271	0.014	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000255	0.0132	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000255	0.0132	CbGpPWpGaD
Danazol—PGR—lung—allergic rhinitis	0.000248	0.0253	CbGeAlD
Danazol—CYP19A1—Ovarian Infertility Genes—SMAD3—allergic rhinitis	0.000236	0.0122	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000229	0.0119	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000223	0.0115	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL4—allergic rhinitis	0.000222	0.0115	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000219	0.0114	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	0.000218	0.0113	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000213	0.011	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000212	0.011	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000212	0.011	CbGpPWpGaD
Danazol—CCL2—IL-1 signaling pathway—NFKB1—allergic rhinitis	0.000206	0.0106	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.0002	0.0104	CbGpPWpGaD
Danazol—AR—lung—allergic rhinitis	0.000197	0.0202	CbGeAlD
Danazol—GNRHR—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000194	0.0101	CbGpPWpGaD
Danazol—ESR1—lung—allergic rhinitis	0.000194	0.0198	CbGeAlD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000194	0.01	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00019	0.00984	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL5—allergic rhinitis	0.000185	0.0096	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.00018	0.00932	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—NFKB1—allergic rhinitis	0.000178	0.0092	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000176	0.00913	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000167	0.00864	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CCL11—allergic rhinitis	0.000161	0.00835	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL5—allergic rhinitis	0.00016	0.00831	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000154	0.00797	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000153	0.00791	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL11—allergic rhinitis	0.000147	0.00764	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL5—allergic rhinitis	0.000143	0.00739	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TGFB1—allergic rhinitis	0.000141	0.00731	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000141	0.00731	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000141	0.00729	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.00014	0.00724	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	0.000136	0.00706	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—allergic rhinitis	0.000135	0.00702	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—allergic rhinitis	0.00013	0.00675	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000128	0.00664	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—SMAD3—allergic rhinitis	0.000121	0.00626	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—CD4—allergic rhinitis	0.000119	0.00616	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000118	0.00611	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL10—allergic rhinitis	0.000117	0.00607	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—TAC1—allergic rhinitis	0.000117	0.00607	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000115	0.00598	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL4—allergic rhinitis	0.000114	0.00591	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00011	0.00569	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000109	0.00565	CbGpPWpGaD
Danazol—Dermatitis—Diphenhydramine—allergic rhinitis	0.000107	0.00154	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—TAC1—allergic rhinitis	0.000107	0.00555	CbGpPWpGaD
Danazol—Dyspepsia—Flunisolide—allergic rhinitis	0.000107	0.00154	CcSEcCtD
Danazol—Headache—Diphenhydramine—allergic rhinitis	0.000107	0.00153	CcSEcCtD
Danazol—Headache—Dimenhydrinate—allergic rhinitis	0.000107	0.00153	CcSEcCtD
Danazol—Fatigue—Cetirizine—allergic rhinitis	0.000106	0.00153	CcSEcCtD
Danazol—Constipation—Cetirizine—allergic rhinitis	0.000105	0.00152	CcSEcCtD
Danazol—Affect lability—Triamcinolone—allergic rhinitis	0.000105	0.00152	CcSEcCtD
Danazol—Affect lability—Methylprednisolone—allergic rhinitis	0.000105	0.00151	CcSEcCtD
Danazol—Fatigue—Flunisolide—allergic rhinitis	0.000104	0.0015	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—allergic rhinitis	0.000104	0.0054	CbGpPWpGaD
Danazol—Abdominal pain upper—Hydrocortisone—allergic rhinitis	0.000104	0.00149	CcSEcCtD
Danazol—Constipation—Flunisolide—allergic rhinitis	0.000104	0.00149	CcSEcCtD
Danazol—Body temperature increased—Loratadine—allergic rhinitis	0.000104	0.00149	CcSEcCtD
Danazol—Oedema—Montelukast—allergic rhinitis	0.000103	0.00149	CcSEcCtD
Danazol—Nausea—Olopatadine—allergic rhinitis	0.000103	0.00149	CcSEcCtD
Danazol—Visual disturbance—Dexamethasone—allergic rhinitis	0.000102	0.00147	CcSEcCtD
Danazol—Visual disturbance—Betamethasone—allergic rhinitis	0.000102	0.00147	CcSEcCtD
Danazol—Irritability—Methylprednisolone—allergic rhinitis	0.000102	0.00147	CcSEcCtD
Danazol—Mood swings—Triamcinolone—allergic rhinitis	0.000101	0.00146	CcSEcCtD
Danazol—Thrombocytopenia—Montelukast—allergic rhinitis	0.000101	0.00146	CcSEcCtD
Danazol—Mood swings—Methylprednisolone—allergic rhinitis	0.000101	0.00146	CcSEcCtD
Danazol—Nausea—Dimenhydrinate—allergic rhinitis	0.000101	0.00146	CcSEcCtD
Danazol—Nausea—Diphenhydramine—allergic rhinitis	0.000101	0.00146	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Flunisolide—allergic rhinitis	0.000101	0.0371	CbGdCrCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—allergic rhinitis	0.0001	0.0052	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PTGDR2—allergic rhinitis	9.98e-05	0.00517	CbGpPWpGaD
Danazol—Pancreatitis—Prednisolone—allergic rhinitis	9.85e-05	0.00142	CcSEcCtD
Danazol—Urticaria—Cetirizine—allergic rhinitis	9.79e-05	0.00141	CcSEcCtD
Danazol—Body temperature increased—Cetirizine—allergic rhinitis	9.74e-05	0.0014	CcSEcCtD
Danazol—Urticaria—Flunisolide—allergic rhinitis	9.63e-05	0.00139	CcSEcCtD
Danazol—Pancreatitis—Hydrocortisone—allergic rhinitis	9.62e-05	0.00139	CcSEcCtD
Danazol—Body temperature increased—Flunisolide—allergic rhinitis	9.58e-05	0.00138	CcSEcCtD
Danazol—Migraine—Dexamethasone—allergic rhinitis	9.55e-05	0.00138	CcSEcCtD
Danazol—Affect lability—Betamethasone—allergic rhinitis	9.55e-05	0.00138	CcSEcCtD
Danazol—Affect lability—Dexamethasone—allergic rhinitis	9.55e-05	0.00138	CcSEcCtD
Danazol—Migraine—Betamethasone—allergic rhinitis	9.55e-05	0.00138	CcSEcCtD
Danazol—Musculoskeletal discomfort—Montelukast—allergic rhinitis	9.42e-05	0.00136	CcSEcCtD
Danazol—Asthenia—Loratadine—allergic rhinitis	9.4e-05	0.00135	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TGFB1—allergic rhinitis	9.3e-05	0.00482	CbGpPWpGaD
Danazol—Paraesthesia—Montelukast—allergic rhinitis	9.28e-05	0.00134	CcSEcCtD
Danazol—Irritability—Dexamethasone—allergic rhinitis	9.26e-05	0.00133	CcSEcCtD
Danazol—Irritability—Betamethasone—allergic rhinitis	9.26e-05	0.00133	CcSEcCtD
Danazol—Mood swings—Dexamethasone—allergic rhinitis	9.19e-05	0.00132	CcSEcCtD
Danazol—Mood swings—Betamethasone—allergic rhinitis	9.19e-05	0.00132	CcSEcCtD
Danazol—Weight increased—Prednisolone—allergic rhinitis	9.15e-05	0.00132	CcSEcCtD
Danazol—Dyspepsia—Montelukast—allergic rhinitis	9.1e-05	0.00131	CcSEcCtD
Danazol—Pancreatitis—Triamcinolone—allergic rhinitis	9.06e-05	0.00131	CcSEcCtD
Danazol—Pancreatitis—Methylprednisolone—allergic rhinitis	9.04e-05	0.0013	CcSEcCtD
Danazol—Weight increased—Hydrocortisone—allergic rhinitis	8.93e-05	0.00129	CcSEcCtD
Danazol—Fatigue—Montelukast—allergic rhinitis	8.91e-05	0.00128	CcSEcCtD
Danazol—Asthenia—Cetirizine—allergic rhinitis	8.84e-05	0.00127	CcSEcCtD
Danazol—Acute coronary syndrome—Prednisolone—allergic rhinitis	8.83e-05	0.00127	CcSEcCtD
Danazol—Myocardial infarction—Prednisolone—allergic rhinitis	8.78e-05	0.00127	CcSEcCtD
Danazol—Pruritus—Cetirizine—allergic rhinitis	8.72e-05	0.00126	CcSEcCtD
Danazol—Asthenia—Flunisolide—allergic rhinitis	8.7e-05	0.00125	CcSEcCtD
Danazol—Dizziness—Loratadine—allergic rhinitis	8.66e-05	0.00125	CcSEcCtD
Danazol—Acute coronary syndrome—Hydrocortisone—allergic rhinitis	8.63e-05	0.00124	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—CYSLTR1—allergic rhinitis	8.62e-05	0.00447	CbGpPWpGaD
Danazol—Myocardial infarction—Hydrocortisone—allergic rhinitis	8.58e-05	0.00124	CcSEcCtD
Danazol—Pruritus—Flunisolide—allergic rhinitis	8.57e-05	0.00124	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CYSLTR1—allergic rhinitis	8.56e-05	0.00444	CbGpPWpGaD
Danazol—Weight increased—Triamcinolone—allergic rhinitis	8.41e-05	0.00121	CcSEcCtD
Danazol—Weight increased—Methylprednisolone—allergic rhinitis	8.39e-05	0.00121	CcSEcCtD
Danazol—CCL2—Fluocinonide—Flunisolide—allergic rhinitis	8.34e-05	0.0307	CbGdCrCtD
Danazol—Vomiting—Loratadine—allergic rhinitis	8.33e-05	0.0012	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CCL11—allergic rhinitis	8.27e-05	0.00428	CbGpPWpGaD
Danazol—Rash—Loratadine—allergic rhinitis	8.26e-05	0.00119	CcSEcCtD
Danazol—Dermatitis—Loratadine—allergic rhinitis	8.25e-05	0.00119	CcSEcCtD
Danazol—Urticaria—Montelukast—allergic rhinitis	8.21e-05	0.00118	CcSEcCtD
Danazol—Headache—Loratadine—allergic rhinitis	8.21e-05	0.00118	CcSEcCtD
Danazol—Body temperature increased—Montelukast—allergic rhinitis	8.17e-05	0.00118	CcSEcCtD
Danazol—Dizziness—Cetirizine—allergic rhinitis	8.15e-05	0.00117	CcSEcCtD
Danazol—Acute coronary syndrome—Triamcinolone—allergic rhinitis	8.12e-05	0.00117	CcSEcCtD
Danazol—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	8.11e-05	0.00117	CcSEcCtD
Danazol—Haemoglobin—Prednisolone—allergic rhinitis	8.09e-05	0.00116	CcSEcCtD
Danazol—Myocardial infarction—Triamcinolone—allergic rhinitis	8.08e-05	0.00116	CcSEcCtD
Danazol—Myocardial infarction—Methylprednisolone—allergic rhinitis	8.06e-05	0.00116	CcSEcCtD
Danazol—Haemorrhage—Prednisolone—allergic rhinitis	8.04e-05	0.00116	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	8.03e-05	0.00416	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL10—allergic rhinitis	8.02e-05	0.00415	CbGpPWpGaD
Danazol—Dizziness—Flunisolide—allergic rhinitis	8.01e-05	0.00115	CcSEcCtD
Danazol—CCL2—Amcinonide—Flunisolide—allergic rhinitis	8e-05	0.0294	CbGdCrCtD
Danazol—Haemoglobin—Hydrocortisone—allergic rhinitis	7.9e-05	0.00114	CcSEcCtD
Danazol—Sweating—Methylprednisolone—allergic rhinitis	7.88e-05	0.00114	CcSEcCtD
Danazol—Haemorrhage—Hydrocortisone—allergic rhinitis	7.86e-05	0.00113	CcSEcCtD
Danazol—Vomiting—Cetirizine—allergic rhinitis	7.84e-05	0.00113	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CYSLTR1—allergic rhinitis	7.83e-05	0.00406	CbGpPWpGaD
Danazol—Nausea—Loratadine—allergic rhinitis	7.78e-05	0.00112	CcSEcCtD
Danazol—Rash—Cetirizine—allergic rhinitis	7.77e-05	0.00112	CcSEcCtD
Danazol—Dermatitis—Cetirizine—allergic rhinitis	7.76e-05	0.00112	CcSEcCtD
Danazol—Visual impairment—Prednisolone—allergic rhinitis	7.75e-05	0.00112	CcSEcCtD
Danazol—Headache—Cetirizine—allergic rhinitis	7.72e-05	0.00111	CcSEcCtD
Danazol—Vomiting—Flunisolide—allergic rhinitis	7.71e-05	0.00111	CcSEcCtD
Danazol—Rash—Flunisolide—allergic rhinitis	7.64e-05	0.0011	CcSEcCtD
Danazol—Dermatitis—Flunisolide—allergic rhinitis	7.63e-05	0.0011	CcSEcCtD
Danazol—Weight increased—Dexamethasone—allergic rhinitis	7.63e-05	0.0011	CcSEcCtD
Danazol—Weight increased—Betamethasone—allergic rhinitis	7.63e-05	0.0011	CcSEcCtD
Danazol—Headache—Flunisolide—allergic rhinitis	7.59e-05	0.00109	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CCL11—allergic rhinitis	7.56e-05	0.00392	CbGpPWpGaD
Danazol—Haemoglobin—Triamcinolone—allergic rhinitis	7.44e-05	0.00107	CcSEcCtD
Danazol—Haemoglobin—Methylprednisolone—allergic rhinitis	7.42e-05	0.00107	CcSEcCtD
Danazol—Asthenia—Montelukast—allergic rhinitis	7.42e-05	0.00107	CcSEcCtD
Danazol—Haemorrhage—Triamcinolone—allergic rhinitis	7.4e-05	0.00107	CcSEcCtD
Danazol—Haemorrhage—Methylprednisolone—allergic rhinitis	7.38e-05	0.00106	CcSEcCtD
Danazol—Acute coronary syndrome—Betamethasone—allergic rhinitis	7.37e-05	0.00106	CcSEcCtD
Danazol—Acute coronary syndrome—Dexamethasone—allergic rhinitis	7.37e-05	0.00106	CcSEcCtD
Danazol—Myocardial infarction—Dexamethasone—allergic rhinitis	7.33e-05	0.00106	CcSEcCtD
Danazol—Myocardial infarction—Betamethasone—allergic rhinitis	7.33e-05	0.00106	CcSEcCtD
Danazol—Nausea—Cetirizine—allergic rhinitis	7.32e-05	0.00105	CcSEcCtD
Danazol—Pruritus—Montelukast—allergic rhinitis	7.31e-05	0.00105	CcSEcCtD
Danazol—Nausea—Flunisolide—allergic rhinitis	7.2e-05	0.00104	CcSEcCtD
Danazol—Visual impairment—Methylprednisolone—allergic rhinitis	7.11e-05	0.00102	CcSEcCtD
Danazol—Dizziness—Montelukast—allergic rhinitis	6.84e-05	0.000984	CcSEcCtD
Danazol—Haemoglobin—Dexamethasone—allergic rhinitis	6.75e-05	0.000972	CcSEcCtD
Danazol—Haemoglobin—Betamethasone—allergic rhinitis	6.75e-05	0.000972	CcSEcCtD
Danazol—Haemorrhage—Betamethasone—allergic rhinitis	6.71e-05	0.000967	CcSEcCtD
Danazol—Haemorrhage—Dexamethasone—allergic rhinitis	6.71e-05	0.000967	CcSEcCtD
Danazol—Vision blurred—Prednisolone—allergic rhinitis	6.6e-05	0.000951	CcSEcCtD
Danazol—Vomiting—Montelukast—allergic rhinitis	6.57e-05	0.000947	CcSEcCtD
Danazol—Rash—Montelukast—allergic rhinitis	6.52e-05	0.000939	CcSEcCtD
Danazol—Dermatitis—Montelukast—allergic rhinitis	6.51e-05	0.000938	CcSEcCtD
Danazol—Headache—Montelukast—allergic rhinitis	6.48e-05	0.000933	CcSEcCtD
Danazol—Visual impairment—Betamethasone—allergic rhinitis	6.47e-05	0.000932	CcSEcCtD
Danazol—Visual impairment—Dexamethasone—allergic rhinitis	6.47e-05	0.000932	CcSEcCtD
Danazol—CCL2—Signaling Pathways—PTGDR2—allergic rhinitis	6.44e-05	0.00334	CbGpPWpGaD
Danazol—Vertigo—Prednisolone—allergic rhinitis	6.29e-05	0.000906	CcSEcCtD
Danazol—Syncope—Prednisolone—allergic rhinitis	6.28e-05	0.000904	CcSEcCtD
Danazol—CCL2—Fluorometholone—Flunisolide—allergic rhinitis	6.25e-05	0.023	CbGdCrCtD
Danazol—Back pain—Triamcinolone—allergic rhinitis	6.23e-05	0.000897	CcSEcCtD
Danazol—CCL2—Flurandrenolide—Flunisolide—allergic rhinitis	6.21e-05	0.0228	CbGdCrCtD
Danazol—Loss of consciousness—Prednisolone—allergic rhinitis	6.15e-05	0.000886	CcSEcCtD
Danazol—Vertigo—Hydrocortisone—allergic rhinitis	6.14e-05	0.000885	CcSEcCtD
Danazol—Nausea—Montelukast—allergic rhinitis	6.14e-05	0.000884	CcSEcCtD
Danazol—Syncope—Hydrocortisone—allergic rhinitis	6.13e-05	0.000883	CcSEcCtD
Danazol—Convulsion—Prednisolone—allergic rhinitis	6.07e-05	0.000874	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—TAC1—allergic rhinitis	6.05e-05	0.00314	CbGpPWpGaD
Danazol—Hypertension—Prednisolone—allergic rhinitis	6.05e-05	0.000871	CcSEcCtD
Danazol—Loss of consciousness—Hydrocortisone—allergic rhinitis	6.01e-05	0.000866	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—TAC1—allergic rhinitis	6.01e-05	0.00311	CbGpPWpGaD
Danazol—Alopecia—Dexamethasone—allergic rhinitis	5.93e-05	0.000854	CcSEcCtD
Danazol—Alopecia—Betamethasone—allergic rhinitis	5.93e-05	0.000854	CcSEcCtD
Danazol—Convulsion—Hydrocortisone—allergic rhinitis	5.93e-05	0.000853	CcSEcCtD
Danazol—Hypertension—Hydrocortisone—allergic rhinitis	5.9e-05	0.00085	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—PTGDR2—allergic rhinitis	5.89e-05	0.00305	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—NFKB1—allergic rhinitis	5.87e-05	0.00304	CbGpPWpGaD
Danazol—Anxiety—Hydrocortisone—allergic rhinitis	5.8e-05	0.000836	CcSEcCtD
Danazol—Vertigo—Triamcinolone—allergic rhinitis	5.79e-05	0.000833	CcSEcCtD
Danazol—Syncope—Triamcinolone—allergic rhinitis	5.78e-05	0.000832	CcSEcCtD
Danazol—Vertigo—Methylprednisolone—allergic rhinitis	5.77e-05	0.000831	CcSEcCtD
Danazol—Syncope—Methylprednisolone—allergic rhinitis	5.76e-05	0.00083	CcSEcCtD
Danazol—Oedema—Prednisolone—allergic rhinitis	5.72e-05	0.000823	CcSEcCtD
Danazol—Loss of consciousness—Triamcinolone—allergic rhinitis	5.66e-05	0.000815	CcSEcCtD
Danazol—Loss of consciousness—Methylprednisolone—allergic rhinitis	5.65e-05	0.000813	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—IL5—allergic rhinitis	5.63e-05	0.00291	CbGpPWpGaD
Danazol—Shock—Prednisolone—allergic rhinitis	5.62e-05	0.00081	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—IL5—allergic rhinitis	5.59e-05	0.00289	CbGpPWpGaD
Danazol—Oedema—Hydrocortisone—allergic rhinitis	5.58e-05	0.000804	CcSEcCtD
Danazol—Convulsion—Triamcinolone—allergic rhinitis	5.58e-05	0.000804	CcSEcCtD
Danazol—Tachycardia—Prednisolone—allergic rhinitis	5.58e-05	0.000803	CcSEcCtD
Danazol—Convulsion—Methylprednisolone—allergic rhinitis	5.57e-05	0.000802	CcSEcCtD
Danazol—Hypertension—Triamcinolone—allergic rhinitis	5.56e-05	0.000801	CcSEcCtD
Danazol—Hypertension—Methylprednisolone—allergic rhinitis	5.55e-05	0.000799	CcSEcCtD
Danazol—Hyperhidrosis—Prednisolone—allergic rhinitis	5.53e-05	0.000796	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—TAC1—allergic rhinitis	5.49e-05	0.00285	CbGpPWpGaD
Danazol—Shock—Hydrocortisone—allergic rhinitis	5.49e-05	0.000791	CcSEcCtD
Danazol—Arthralgia—Methylprednisolone—allergic rhinitis	5.47e-05	0.000788	CcSEcCtD
Danazol—Anxiety—Methylprednisolone—allergic rhinitis	5.45e-05	0.000785	CcSEcCtD
Danazol—Tachycardia—Hydrocortisone—allergic rhinitis	5.45e-05	0.000785	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—NFKB1—allergic rhinitis	5.43e-05	0.00281	CbGpPWpGaD
Danazol—Hyperhidrosis—Hydrocortisone—allergic rhinitis	5.4e-05	0.000777	CcSEcCtD
Danazol—Oedema—Triamcinolone—allergic rhinitis	5.26e-05	0.000757	CcSEcCtD
Danazol—Vertigo—Betamethasone—allergic rhinitis	5.25e-05	0.000756	CcSEcCtD
Danazol—Vertigo—Dexamethasone—allergic rhinitis	5.25e-05	0.000756	CcSEcCtD
Danazol—Syncope—Dexamethasone—allergic rhinitis	5.24e-05	0.000755	CcSEcCtD
Danazol—Syncope—Betamethasone—allergic rhinitis	5.24e-05	0.000755	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Hydrocortisone—allergic rhinitis	5.23e-05	0.0192	CbGdCrCtD
Danazol—Shock—Triamcinolone—allergic rhinitis	5.17e-05	0.000745	CcSEcCtD
Danazol—CCL2—Triamcinolone—Flunisolide—allergic rhinitis	5.16e-05	0.019	CbGdCrCtD
Danazol—Shock—Methylprednisolone—allergic rhinitis	5.16e-05	0.000743	CcSEcCtD
Danazol—Loss of consciousness—Betamethasone—allergic rhinitis	5.14e-05	0.00074	CcSEcCtD
Danazol—Loss of consciousness—Dexamethasone—allergic rhinitis	5.14e-05	0.00074	CcSEcCtD
Danazol—Paraesthesia—Prednisolone—allergic rhinitis	5.13e-05	0.000739	CcSEcCtD
Danazol—Tachycardia—Triamcinolone—allergic rhinitis	5.13e-05	0.000739	CcSEcCtD
Danazol—Tachycardia—Methylprednisolone—allergic rhinitis	5.12e-05	0.000737	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—IL5—allergic rhinitis	5.11e-05	0.00265	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	5.09e-05	0.000732	CcSEcCtD
Danazol—Hyperhidrosis—Triamcinolone—allergic rhinitis	5.08e-05	0.000732	CcSEcCtD
Danazol—Hyperhidrosis—Methylprednisolone—allergic rhinitis	5.07e-05	0.00073	CcSEcCtD
Danazol—Convulsion—Betamethasone—allergic rhinitis	5.06e-05	0.000729	CcSEcCtD
Danazol—Convulsion—Dexamethasone—allergic rhinitis	5.06e-05	0.000729	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CYSLTR1—allergic rhinitis	5.06e-05	0.00262	CbGpPWpGaD
Danazol—Hypertension—Dexamethasone—allergic rhinitis	5.04e-05	0.000727	CcSEcCtD
Danazol—Hypertension—Betamethasone—allergic rhinitis	5.04e-05	0.000727	CcSEcCtD
Danazol—CCL2—Fluticasone Propionate—Flunisolide—allergic rhinitis	5.03e-05	0.0185	CbGdCrCtD
Danazol—Paraesthesia—Hydrocortisone—allergic rhinitis	5.01e-05	0.000722	CcSEcCtD
Danazol—Anxiety—Betamethasone—allergic rhinitis	4.96e-05	0.000714	CcSEcCtD
Danazol—Anxiety—Dexamethasone—allergic rhinitis	4.96e-05	0.000714	CcSEcCtD
Danazol—Dyspepsia—Hydrocortisone—allergic rhinitis	4.91e-05	0.000708	CcSEcCtD
Danazol—CCL2—Desoximetasone—Flunisolide—allergic rhinitis	4.9e-05	0.018	CbGdCrCtD
Danazol—ESR1—Regulation of Telomerase—TGFB1—allergic rhinitis	4.89e-05	0.00253	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCL11—allergic rhinitis	4.88e-05	0.00253	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Betamethasone—allergic rhinitis	4.86e-05	0.0178	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Dexamethasone—allergic rhinitis	4.86e-05	0.0178	CbGdCrCtD
Danazol—Fatigue—Hydrocortisone—allergic rhinitis	4.81e-05	0.000693	CcSEcCtD
Danazol—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	4.79e-05	0.00069	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—allergic rhinitis	4.78e-05	0.00248	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	4.78e-05	0.000688	CcSEcCtD
Danazol—Oedema—Betamethasone—allergic rhinitis	4.77e-05	0.000687	CcSEcCtD
Danazol—Oedema—Dexamethasone—allergic rhinitis	4.77e-05	0.000687	CcSEcCtD
Danazol—CCL2—Diflorasone—Flunisolide—allergic rhinitis	4.76e-05	0.0175	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Triamcinolone—allergic rhinitis	4.75e-05	0.0174	CbGdCrCtD
Danazol—Paraesthesia—Triamcinolone—allergic rhinitis	4.72e-05	0.00068	CcSEcCtD
Danazol—Paraesthesia—Methylprednisolone—allergic rhinitis	4.71e-05	0.000678	CcSEcCtD
Danazol—Shock—Dexamethasone—allergic rhinitis	4.69e-05	0.000676	CcSEcCtD
Danazol—Shock—Betamethasone—allergic rhinitis	4.69e-05	0.000676	CcSEcCtD
Danazol—Thrombocytopenia—Dexamethasone—allergic rhinitis	4.67e-05	0.000673	CcSEcCtD
Danazol—Thrombocytopenia—Betamethasone—allergic rhinitis	4.67e-05	0.000673	CcSEcCtD
Danazol—Tachycardia—Dexamethasone—allergic rhinitis	4.65e-05	0.00067	CcSEcCtD
Danazol—Tachycardia—Betamethasone—allergic rhinitis	4.65e-05	0.00067	CcSEcCtD
Danazol—Dyspepsia—Triamcinolone—allergic rhinitis	4.63e-05	0.000666	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—CYSLTR1—allergic rhinitis	4.63e-05	0.0024	CbGpPWpGaD
Danazol—Dyspepsia—Methylprednisolone—allergic rhinitis	4.62e-05	0.000665	CcSEcCtD
Danazol—Hyperhidrosis—Dexamethasone—allergic rhinitis	4.61e-05	0.000664	CcSEcCtD
Danazol—Hyperhidrosis—Betamethasone—allergic rhinitis	4.61e-05	0.000664	CcSEcCtD
Danazol—Urticaria—Prednisolone—allergic rhinitis	4.54e-05	0.000654	CcSEcCtD
Danazol—Fatigue—Triamcinolone—allergic rhinitis	4.53e-05	0.000653	CcSEcCtD
Danazol—Fatigue—Methylprednisolone—allergic rhinitis	4.52e-05	0.000651	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—CCL11—allergic rhinitis	4.47e-05	0.00231	CbGpPWpGaD
Danazol—Urticaria—Hydrocortisone—allergic rhinitis	4.43e-05	0.000639	CcSEcCtD
Danazol—Body temperature increased—Hydrocortisone—allergic rhinitis	4.41e-05	0.000636	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—allergic rhinitis	4.4e-05	0.0162	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Dexamethasone—allergic rhinitis	4.35e-05	0.016	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Betamethasone—allergic rhinitis	4.35e-05	0.016	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	4.34e-05	0.000626	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	4.34e-05	0.000626	CcSEcCtD
Danazol—Paraesthesia—Betamethasone—allergic rhinitis	4.28e-05	0.000617	CcSEcCtD
Danazol—Paraesthesia—Dexamethasone—allergic rhinitis	4.28e-05	0.000617	CcSEcCtD
Danazol—PGR—Generic Transcription Pathway—SMAD3—allergic rhinitis	4.28e-05	0.00222	CbGpPWpGaD
Danazol—CCL2—Beclomethasone—Triamcinolone—allergic rhinitis	4.25e-05	0.0156	CbGdCrCtD
Danazol—Dyspepsia—Betamethasone—allergic rhinitis	4.2e-05	0.000605	CcSEcCtD
Danazol—Dyspepsia—Dexamethasone—allergic rhinitis	4.2e-05	0.000605	CcSEcCtD
Danazol—Urticaria—Triamcinolone—allergic rhinitis	4.18e-05	0.000601	CcSEcCtD
Danazol—CCL2—Budesonide—Flunisolide—allergic rhinitis	4.17e-05	0.0153	CbGdCrCtD
Danazol—Urticaria—Methylprednisolone—allergic rhinitis	4.17e-05	0.0006	CcSEcCtD
Danazol—Body temperature increased—Triamcinolone—allergic rhinitis	4.15e-05	0.000598	CcSEcCtD
Danazol—Fatigue—Betamethasone—allergic rhinitis	4.11e-05	0.000592	CcSEcCtD
Danazol—Fatigue—Dexamethasone—allergic rhinitis	4.11e-05	0.000592	CcSEcCtD
Danazol—CCL2—Fluocinonide—Methylprednisolone—allergic rhinitis	4.08e-05	0.015	CbGdCrCtD
Danazol—AR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	4.03e-05	0.00209	CbGpPWpGaD
Danazol—CCL2—Fluocinonide—Betamethasone—allergic rhinitis	4.02e-05	0.0148	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Dexamethasone—allergic rhinitis	4.02e-05	0.0148	CbGdCrCtD
Danazol—Asthenia—Hydrocortisone—allergic rhinitis	4e-05	0.000577	CcSEcCtD
Danazol—Pruritus—Hydrocortisone—allergic rhinitis	3.95e-05	0.000569	CcSEcCtD
Danazol—CCL2—Beclomethasone—Prednisolone—allergic rhinitis	3.94e-05	0.0145	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Triamcinolone—allergic rhinitis	3.93e-05	0.0144	CbGdCrCtD
Danazol—AR—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	3.92e-05	0.00203	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Betamethasone—allergic rhinitis	3.85e-05	0.0142	CbGdCrCtD
Danazol—CCL2—Amcinonide—Dexamethasone—allergic rhinitis	3.85e-05	0.0142	CbGdCrCtD
Danazol—Urticaria—Betamethasone—allergic rhinitis	3.79e-05	0.000546	CcSEcCtD
Danazol—Urticaria—Dexamethasone—allergic rhinitis	3.79e-05	0.000546	CcSEcCtD
Danazol—Dizziness—Prednisolone—allergic rhinitis	3.78e-05	0.000544	CcSEcCtD
Danazol—Asthenia—Triamcinolone—allergic rhinitis	3.77e-05	0.000543	CcSEcCtD
Danazol—Body temperature increased—Dexamethasone—allergic rhinitis	3.77e-05	0.000543	CcSEcCtD
Danazol—Body temperature increased—Betamethasone—allergic rhinitis	3.77e-05	0.000543	CcSEcCtD
Danazol—CCL2—Amcinonide—Triamcinolone—allergic rhinitis	3.76e-05	0.0138	CbGdCrCtD
Danazol—Asthenia—Methylprednisolone—allergic rhinitis	3.76e-05	0.000542	CcSEcCtD
Danazol—Pruritus—Triamcinolone—allergic rhinitis	3.72e-05	0.000536	CcSEcCtD
Danazol—PGR—Signaling Pathways—PTGDR2—allergic rhinitis	3.72e-05	0.00193	CbGpPWpGaD
Danazol—Pruritus—Methylprednisolone—allergic rhinitis	3.71e-05	0.000534	CcSEcCtD
Danazol—Dizziness—Hydrocortisone—allergic rhinitis	3.69e-05	0.000532	CcSEcCtD
Danazol—Rash—Prednisolone—allergic rhinitis	3.6e-05	0.000519	CcSEcCtD
Danazol—Dermatitis—Prednisolone—allergic rhinitis	3.6e-05	0.000519	CcSEcCtD
Danazol—Headache—Prednisolone—allergic rhinitis	3.58e-05	0.000516	CcSEcCtD
Danazol—Vomiting—Hydrocortisone—allergic rhinitis	3.55e-05	0.000511	CcSEcCtD
Danazol—CCL2—Signaling Pathways—TAC1—allergic rhinitis	3.55e-05	0.00184	CbGpPWpGaD
Danazol—Rash—Hydrocortisone—allergic rhinitis	3.52e-05	0.000507	CcSEcCtD
Danazol—Dermatitis—Hydrocortisone—allergic rhinitis	3.52e-05	0.000506	CcSEcCtD
Danazol—Headache—Hydrocortisone—allergic rhinitis	3.5e-05	0.000504	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisolone—allergic rhinitis	3.49e-05	0.0128	CbGdCrCtD
Danazol—Dizziness—Triamcinolone—allergic rhinitis	3.48e-05	0.000501	CcSEcCtD
Danazol—Dizziness—Methylprednisolone—allergic rhinitis	3.47e-05	0.000499	CcSEcCtD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	3.46e-05	0.00179	CbGpPWpGaD
Danazol—Asthenia—Dexamethasone—allergic rhinitis	3.42e-05	0.000493	CcSEcCtD
Danazol—Asthenia—Betamethasone—allergic rhinitis	3.42e-05	0.000493	CcSEcCtD
Danazol—Nausea—Prednisolone—allergic rhinitis	3.39e-05	0.000489	CcSEcCtD
Danazol—Pruritus—Dexamethasone—allergic rhinitis	3.37e-05	0.000486	CcSEcCtD
Danazol—Pruritus—Betamethasone—allergic rhinitis	3.37e-05	0.000486	CcSEcCtD
Danazol—Vomiting—Triamcinolone—allergic rhinitis	3.34e-05	0.000481	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.34e-05	0.00173	CbGpPWpGaD
Danazol—Vomiting—Methylprednisolone—allergic rhinitis	3.33e-05	0.00048	CcSEcCtD
Danazol—Nausea—Hydrocortisone—allergic rhinitis	3.32e-05	0.000478	CcSEcCtD
Danazol—Rash—Triamcinolone—allergic rhinitis	3.31e-05	0.000477	CcSEcCtD
Danazol—Dermatitis—Triamcinolone—allergic rhinitis	3.31e-05	0.000477	CcSEcCtD
Danazol—Rash—Methylprednisolone—allergic rhinitis	3.31e-05	0.000476	CcSEcCtD
Danazol—Dermatitis—Methylprednisolone—allergic rhinitis	3.3e-05	0.000476	CcSEcCtD
Danazol—CCL2—Signaling Pathways—IL5—allergic rhinitis	3.3e-05	0.00171	CbGpPWpGaD
Danazol—Headache—Triamcinolone—allergic rhinitis	3.29e-05	0.000474	CcSEcCtD
Danazol—Headache—Methylprednisolone—allergic rhinitis	3.29e-05	0.000473	CcSEcCtD
Danazol—AR—Generic Transcription Pathway—SMAD3—allergic rhinitis	3.26e-05	0.00169	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TAC1—allergic rhinitis	3.25e-05	0.00168	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Hydrocortisone—allergic rhinitis	3.24e-05	0.0119	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Hydrocortisone—allergic rhinitis	3.22e-05	0.0118	CbGdCrCtD
Danazol—Dizziness—Betamethasone—allergic rhinitis	3.15e-05	0.000454	CcSEcCtD
Danazol—Dizziness—Dexamethasone—allergic rhinitis	3.15e-05	0.000454	CcSEcCtD
Danazol—Nausea—Triamcinolone—allergic rhinitis	3.12e-05	0.00045	CcSEcCtD
Danazol—Nausea—Methylprednisolone—allergic rhinitis	3.11e-05	0.000449	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	3.1e-05	0.00161	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Methylprednisolone—allergic rhinitis	3.06e-05	0.0112	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Methylprednisolone—allergic rhinitis	3.04e-05	0.0112	CbGdCrCtD
Danazol—Vomiting—Betamethasone—allergic rhinitis	3.03e-05	0.000437	CcSEcCtD
Danazol—Vomiting—Dexamethasone—allergic rhinitis	3.03e-05	0.000437	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—IL5—allergic rhinitis	3.02e-05	0.00156	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Dexamethasone—allergic rhinitis	3.01e-05	0.0111	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Betamethasone—allergic rhinitis	3.01e-05	0.0111	CbGdCrCtD
Danazol—Rash—Dexamethasone—allergic rhinitis	3.01e-05	0.000433	CcSEcCtD
Danazol—Rash—Betamethasone—allergic rhinitis	3.01e-05	0.000433	CcSEcCtD
Danazol—Dermatitis—Dexamethasone—allergic rhinitis	3e-05	0.000433	CcSEcCtD
Danazol—Dermatitis—Betamethasone—allergic rhinitis	3e-05	0.000433	CcSEcCtD
Danazol—CCL2—Flurandrenolide—Dexamethasone—allergic rhinitis	2.99e-05	0.011	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Betamethasone—allergic rhinitis	2.99e-05	0.011	CbGdCrCtD
Danazol—Headache—Betamethasone—allergic rhinitis	2.99e-05	0.00043	CcSEcCtD
Danazol—Headache—Dexamethasone—allergic rhinitis	2.99e-05	0.00043	CcSEcCtD
Danazol—CCL2—Fluorometholone—Triamcinolone—allergic rhinitis	2.94e-05	0.0108	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CYSLTR1—allergic rhinitis	2.92e-05	0.00151	CbGpPWpGaD
Danazol—Nausea—Betamethasone—allergic rhinitis	2.83e-05	0.000408	CcSEcCtD
Danazol—Nausea—Dexamethasone—allergic rhinitis	2.83e-05	0.000408	CcSEcCtD
Danazol—PGR—Signaling Pathways—CCL11—allergic rhinitis	2.82e-05	0.00146	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.78e-05	0.00144	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Prednisolone—allergic rhinitis	2.72e-05	0.01	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—allergic rhinitis	2.71e-05	0.00995	CbGdCrCtD
Danazol—CCL2—Flunisolide—Hydrocortisone—allergic rhinitis	2.71e-05	0.00994	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Hydrocortisone—allergic rhinitis	2.68e-05	0.00984	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Methylprednisolone—allergic rhinitis	2.59e-05	0.00951	CbGdCrCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.57e-05	0.00133	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Methylprednisolone—allergic rhinitis	2.55e-05	0.00938	CbGdCrCtD
Danazol—CCL2—Betamethasone—Flunisolide—allergic rhinitis	2.55e-05	0.00938	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Flunisolide—allergic rhinitis	2.55e-05	0.00938	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Betamethasone—allergic rhinitis	2.55e-05	0.00936	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Dexamethasone—allergic rhinitis	2.55e-05	0.00936	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Hydrocortisone—allergic rhinitis	2.54e-05	0.00935	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Methylprednisolone—allergic rhinitis	2.53e-05	0.00929	CbGdCrCtD
Danazol—CCL2—Flunisolide—Betamethasone—allergic rhinitis	2.51e-05	0.00923	CbGdCrCtD
Danazol—CCL2—Flunisolide—Dexamethasone—allergic rhinitis	2.51e-05	0.00923	CbGdCrCtD
Danazol—ESR1—Generic Transcription Pathway—SMAD3—allergic rhinitis	2.51e-05	0.0013	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Triamcinolone—allergic rhinitis	2.49e-05	0.00914	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Dexamethasone—allergic rhinitis	2.49e-05	0.00914	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Betamethasone—allergic rhinitis	2.49e-05	0.00914	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	2.46e-05	0.00906	CbGdCrCtD
Danazol—CCL2—Flunisolide—Triamcinolone—allergic rhinitis	2.45e-05	0.00902	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Betamethasone—allergic rhinitis	2.43e-05	0.00891	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	2.43e-05	0.00891	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Methylprednisolone—allergic rhinitis	2.4e-05	0.00882	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	2.37e-05	0.00871	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Dexamethasone—allergic rhinitis	2.36e-05	0.00868	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Betamethasone—allergic rhinitis	2.36e-05	0.00868	CbGdCrCtD
Danazol—CCL2—Diflorasone—Methylprednisolone—allergic rhinitis	2.33e-05	0.00856	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—SMAD3—allergic rhinitis	2.32e-05	0.0012	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Triamcinolone—allergic rhinitis	2.31e-05	0.00848	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisolone—allergic rhinitis	2.3e-05	0.00847	CbGdCrCtD
Danazol—CCL2—Diflorasone—Dexamethasone—allergic rhinitis	2.29e-05	0.00842	CbGdCrCtD
Danazol—CCL2—Diflorasone—Betamethasone—allergic rhinitis	2.29e-05	0.00842	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisolone—allergic rhinitis	2.27e-05	0.00836	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisolone—allergic rhinitis	2.25e-05	0.00827	CbGdCrCtD
Danazol—CCL2—Diflorasone—Triamcinolone—allergic rhinitis	2.24e-05	0.00823	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—PTGDR2—allergic rhinitis	2.18e-05	0.00113	CbGpPWpGaD
Danazol—CCL2—Budesonide—Hydrocortisone—allergic rhinitis	2.16e-05	0.00795	CbGdCrCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.14e-05	0.00111	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Prednisolone—allergic rhinitis	2.14e-05	0.00786	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—SMAD3—allergic rhinitis	2.12e-05	0.0011	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Prednisolone—allergic rhinitis	2.07e-05	0.00762	CbGdCrCtD
Danazol—PGR—Gene Expression—SMAD3—allergic rhinitis	2.06e-05	0.00107	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TAC1—allergic rhinitis	2.05e-05	0.00106	CbGpPWpGaD
Danazol—CCL2—Budesonide—Methylprednisolone—allergic rhinitis	2.04e-05	0.0075	CbGdCrCtD
Danazol—CCL2—Budesonide—Dexamethasone—allergic rhinitis	2.01e-05	0.00739	CbGdCrCtD
Danazol—CCL2—Budesonide—Betamethasone—allergic rhinitis	2.01e-05	0.00739	CbGdCrCtD
Danazol—CCL2—Budesonide—Triamcinolone—allergic rhinitis	1.96e-05	0.00722	CbGdCrCtD
Danazol—PGR—Signaling Pathways—IL5—allergic rhinitis	1.9e-05	0.000986	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisolone—allergic rhinitis	1.82e-05	0.00668	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.71e-05	0.000887	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL11—allergic rhinitis	1.65e-05	0.000857	CbGpPWpGaD
Danazol—AR—Gene Expression—SMAD3—allergic rhinitis	1.57e-05	0.000813	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SMAD3—allergic rhinitis	1.34e-05	0.000694	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Hydrocortisone—allergic rhinitis	1.32e-05	0.00486	CbGdCrCtD
Danazol—CCL2—Betamethasone—Hydrocortisone—allergic rhinitis	1.32e-05	0.00486	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Methylprednisolone—allergic rhinitis	1.25e-05	0.00459	CbGdCrCtD
Danazol—CCL2—Betamethasone—Methylprednisolone—allergic rhinitis	1.25e-05	0.00459	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Betamethasone—allergic rhinitis	1.23e-05	0.00452	CbGdCrCtD
Danazol—CCL2—Betamethasone—Dexamethasone—allergic rhinitis	1.23e-05	0.00452	CbGdCrCtD
Danazol—ESR1—Gene Expression—SMAD3—allergic rhinitis	1.21e-05	0.000626	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TAC1—allergic rhinitis	1.2e-05	0.000622	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Triamcinolone—allergic rhinitis	1.2e-05	0.00441	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Triamcinolone—allergic rhinitis	1.2e-05	0.00441	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—NFKB1—allergic rhinitis	1.18e-05	0.000612	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL5—allergic rhinitis	1.12e-05	0.000579	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Prednisolone—allergic rhinitis	1.11e-05	0.00409	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisolone—allergic rhinitis	1.11e-05	0.00409	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—NFKB1—allergic rhinitis	1.08e-05	0.000559	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—allergic rhinitis	9.83e-06	0.000509	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—allergic rhinitis	8.99e-06	0.000466	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMAD3—allergic rhinitis	7.86e-06	0.000407	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKB1—allergic rhinitis	6.81e-06	0.000353	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—allergic rhinitis	5.67e-06	0.000294	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKB1—allergic rhinitis	4e-06	0.000207	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—allergic rhinitis	3.33e-06	0.000172	CbGpPWpGaD
